Allos Therapeutics (ALTH) Dips Ahead Of FDA Decision

Allos Therapeutics (ALTH) is down almost 10% to $7 ahead of a September 2 announcement from a regulatory panel which is reviewing its cancer drug candidate pralatrexate.

There is no other news that might move the stock

Douglas A. McIntyre

Comments

BioHealth Investor RSS Feed

• 

• Recent Posts

  • Questor Meets FDA Snag (QCOR)
  • Renhuang Pharmaceuticals Up On Little News
  • ZymoGenetics Skyrockets On Bristol-Meyers Buyout
  • K-V Hangs On To NYSE Listing
  • Indenix Suffers From FDA Hold

• Archives

  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009

• Categories

  • Acquisitions
  • alzheimer's
  • analyst calls
  • Anemia
  • Atherosclerosis
  • blogfile
  • Cancer
  • Cardiac
  • Contraceptives
  • daily
  • dendreon
  • Depression
  • Devices
  • Diabetes
  • Diagnostics
  • Epilepsy
  • erectile dysfunction
  • fda
  • fibromyalgia
  • Financial
  • flu
  • General
  • generic drugs
  • genomics
  • Heart
  • Hepatitis C
  • Infections
  • Lung
  • Lupus
  • M&A
  • merck
  • mesothelioma
  • MRSA
  • multiple sclerosis
  • obesity
  • Options
  • osteoporosis
  • papilloma virus
  • politics
  • psoriasis
  • R&D
  • Research
  • rheumatoid arthritis
  • shingles
  • Sleep Disorder
  • stem cells
  • targacept
  • Uncategorized
  • vaccine

• Latest from 247Wallst.com

  • The Continually Shrinking Consumer Credit (V, MA, DFS, AXP)
  • EIA Publishes New Estimates; OPEC Produces Less Oil
  • Beige Book: Decelerating Growth Prevails
  • Apple to Sell 28 Million iPads in 2011?
  • Nokia CEO Kallasvuo Defies The Skeptics

• Latest from VSInvestor

  • A Petering-Out in Brocade? (BRCD, DELL, HPQ, PAR, CSCO)
  • ZymoGenetics Continues Projectory In Premarket
  • With Hurd As New Pres, Oracle Jumps Pre-Market
  • Finisar Continues Moving Volume After Announcing Q1 Earnings
  • Mariner: Explosion/Fire Causes Volume Explosion (ME, APA, BP)

• Biotech Resources

  • BIO.com
  • BIO.org
  • BioSpace
  • Centient Biotech Investor
  • Council For Biotech Info
  • EOFHR
  • Nature Biotechnology
  • TR Biotech
  • Yahoo! Finance: Healthcare

• More on Money & Finance

  • AMT
  • Banking
  • Black Friday Deals
  • Credit Cards
  • Credit Reports
  • DailyFinance
  • DJIA
  • Earnings
  • Identity Theft
  • Income Tax Basics
  • Insurance
  • Loans
  • Luxist
  • Market News
  • Money
  • Mortgages
  • Online Tax Filing
  • Recession
  • Retirement
  • Small Business
  • Stock Charts
  • Stock Quotes
  • Stock Ticker
  • Tax Credit
  • Tax Deduction
  • Taxes
  • Walletpop